Dermatology
Oral Dapsone in Refractory Rosacea: Defining a High Inflammatory Burden Subtype to Guide Precision Treatment
This exploratory study suggests oral dapsone benefits refractory rosacea patients, highlighting a ‘high inflammatory burden’ subtype that may predict treatment response, offering a framework for precision dermatologic care.
